MGMT and neoplasm: Nevertheless, CR rates require cautious interpretation for two key reasons: first, BEV may reduce MRI contrast enhancement through decreased vascular permeability rather than true tumor regression; second, the frequent pseudoprogression in MGMT-methylated tumors that shows rapid improvement with BEV could be misinterpreted as therapeutic response (36).